Published in:
01-12-2017 | Medical Comorbidities (M Miner, S Parish and A Goldstein, Section Editors)
Vascular Erectile Dysfunction and Subclinical Cardiovascular Disease
Published in: Current Sexual Health Reports | Issue 4/2017
Login to get accessAbstract
Purpose of Review
We review the recent literature on the hypothesized temporal relationship between subclinical cardiovascular disease (CVD), vascular erectile dysfunction (ED), and clinical CVD. In addition, we combine emerging research with expert consensus guidelines such as The Princeton Consensus III to provide a preventive cardiologist’s perspective toward an ideal approach to evaluating and managing CVD and ED risk in patients.
Recent Findings
Development of ED was found to occur during the progression from subclinical CVD to clinical CVD. A strong association was observed between subclinical CVD as assessed by coronary artery calcium (CAC) and carotid plaque and subsequent ED, providing evidence for the role of subclinical CVD in predicting ED. ED is also identified as a substantial independent risk factor for overt clinical CVD, and ED symptoms may precede CVD symptoms by 2–3 years.
Summary
Given the body of evidence on the relationship between subclinical CVD, ED, and clinical CVD, we recommend that all men with vascular ED should undergo cardiovascular risk assessment. We further recommend using CAC scores for advanced risk assessment in patients at low–intermediate to intermediate risk (5–20% CVD risk), with risk driving subsequent lifestyle and pharmacologic treatment decisions.